Daphne Quimi - Net Worth and Insider Trading

Daphne Quimi Net Worth

The estimated net worth of Daphne Quimi is at least $5 Million dollars as of 2024-03-29. Daphne Quimi is the CFO of Amicus Therapeutics Inc and owns about 398,532 shares of Amicus Therapeutics Inc (FOLD) stock worth over $5 Million. Details can be seen in Daphne Quimi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daphne Quimi has not made any transactions after 2023-01-18 and currently still holds the listed stock(s).

Transaction Summary of Daphne Quimi

To

Daphne Quimi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daphne Quimi owns 3 companies in total, including Amicus Therapeutics Inc () , Amylyx Pharmaceuticals Inc () , and Century Therapeutics Inc () .

Click here to see the complete history of Daphne Quimi’s form 4 insider trades.

Insider Ownership Summary of Daphne Quimi

Ticker Comapny Transaction Date Type of Owner
Amicus Therapeutics Inc 2023-01-18 Chief Financial Officer
Amylyx Pharmaceuticals Inc 2022-01-06 director
Century Therapeutics Inc 2022-10-01 director

Daphne Quimi Latest Holdings Summary

Daphne Quimi currently owns a total of 1 stock. Daphne Quimi owns 398,532 shares of Amicus Therapeutics Inc (FOLD) as of January 18, 2023, with a value of $5 Million.

Latest Holdings of Daphne Quimi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOLD Amicus Therapeutics Inc 2023-01-18 398,532 11.75 4,682,751

Holding Weightings of Daphne Quimi


Daphne Quimi Form 4 Trading Tracker

According to the SEC Form 4 filings, Daphne Quimi has made a total of 8 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 11,923 shares on January 18, 2023, which brought Daphne Quimi around $152,495.

Insider Trading History of Daphne Quimi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daphne Quimi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daphne Quimi Ownership Network

Ownership Network List of Daphne Quimi

No Data

Ownership Network Relation of Daphne Quimi


Daphne Quimi Owned Company Details

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Daphne Quimi is the Chief Financial Officer of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & Executive Chairman John F Crowley , director & President and CEO Bradley L Campbell , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Daphne Quimi made 1 insider transaction in Amicus Therapeutics Inc () with a net sale of 11,923. Other recent insider transactions involving Amicus Therapeutics Inc () include a net sale of 667,360 shares made by John F Crowley , a net sale of 256,386 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .

In summary, during the past 3 months, insiders sold 415,885 shares of Amicus Therapeutics Inc () in total and bought 0 shares, with a net sale of 415,885 shares. During the past 18 months, 1,262,082 shares of Amicus Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,262,082 shares.

Amicus Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amicus Therapeutics Inc Insider Transactions

No Available Data

Daphne Quimi Mailing Address

Above is the net worth, insider trading, and ownership report for Daphne Quimi. You might contact Daphne Quimi via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.

Discussions on Daphne Quimi

No discussions yet.